Frontier Medicines Funding: $80M Raised, Series C (2024)
Frontier Medicines has raised $80M in total funding. Latest round: Series C. Backed by Deerfield, RA Capital, Galapagos.
Frontier Medicines funding overview
Frontier Medicines has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in February 2024. The round record for Frontier Medicines runs through 2024; nothing later has been disclosed. Investors on record include Deerfield, RA Capital, Galapagos. 3 distinct backers are named across the disclosed rounds.
Frontier Medicines at a glance
Total raised
$80M
Latest round
Series C
Latest round date
February 2024
Notable investors
Deerfield, RA Capital, Galapagos
Frequently asked about Frontier Medicines funding
How much has Frontier Medicines raised?
Frontier Medicines has raised $80M in total disclosed funding across the rounds on record.
Who has invested in Frontier Medicines?
Deerfield, RA Capital, Galapagos are named among the investors backing Frontier Medicines.
What was the latest Frontier Medicines funding round?
The most recent disclosed round is a Series C, announced in February 2024.
Where is Frontier Medicines based?
No headquarters location is disclosed for Frontier Medicines.
When did Frontier Medicines last raise?
The last disclosed Frontier Medicines round closed in February 2024 at Series C.
Every Frontier Medicines figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies at a similar stage.
